<?xml version='1.0' encoding='utf-8'?>
<document id="19795925"><sentence text="The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential." /><sentence text="Major advances in the characterization of uridine diphosphate (UDP)-glucuronosyltransferase (UGT) enzyme substrate and inhibitor selectivities and the development of experimental paradigms to investigate xenobiotic glucuronidation in vitro now permit the prediction of a range of drug-glucuronidation parameters in humans"><entity charOffset="42-61" id="DDI-PubMed.19795925.s2.e0" text="uridine diphosphate" /></sentence><sentence text=" In particular, the availability of substrate and inhibitor &quot;probes&quot; for the major hepatic drug metabolizing UGTs together with batteries of recombinant enzymes allow the reaction phenotyping of drug glucuronidation reactions" /><sentence text=" Additionally, in vitro experimental approaches and scaling strategies have been successfully applied to the quantitative prediction of in vivo clearance via glucuronidation and drug-drug interaction potential" /><sentence text="" /></document>